Abstract
The emergence of multi drug resistant clone CC320 serotype19F/19A and their capsular (cps) antigenic variants due to selective pressures such as vaccine had been reported worldwide. Hence, it is important to identify the prevalent clones, sequence types and cps variants of serotype 19F/19A in India, where PCV13 has been recently introduced. Multi-locus sequence typing (MLST) was performed for all (n = 21) invasive S. pneumoniae isolates of serotype 19A (n = 5) and 19F (n = 16) collected between the years 2012 and 2018 from children less than 5 years. The genome characterization by whole genome sequencing for the Sequence types (STs) 320 and 271(n = 7) were performed and compared with another six Indian WGSs of similar STs available from the GPS platform. The predominant STs in the serotype 19F/19A study isolates were of CC320: ST 320, 236 and 271, associated with PMEN clone Taiwan19F-14. The WGSs of CC320 study isolates showed high genomic similarity to the Taiwan19F-14 clone, and the penicillin binding protein (PBP) amino acid sequence similarity was 100% for PBP1A, 93% for PBP 2B and 2X. Whilst PBP comparison with other global MDR ST320 strains revealed that the ST320 clones in India are of low-level penicillin resistance. The presence of a few ST320/19A/19F invasive isolates with high similarity to the Taiwan clone suggests slow and gradual expansion of Taiwan19F-14 associated CC320 clones in India. Since serotype 19F/19A is covered by PCV13 vaccine, the expansion of 19F/19A cones with non-PCV13 vaccine serotype in India should be monitored.
Similar content being viewed by others
References
Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Carlos CC (2012) Changing trend of antimicrobial resistance and serotypes in Streptococcus pneumoniae in Asian countries: an ANSORP study. Antimicrob Agents Chemother 56:1418–1426
Hanage WP, Bishop CJ, Lee GM, Lipsitch M, Stevenson A, Rifas-Shiman SL, Finkelstein JA (2011) Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine 29:8877–8881
Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Hadler JL (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197:1016–1027
Brueggemann AB, Pai R, Crook DW, Beall B (2007) Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 3(11):e168
Naucler P, Galanis I, Morfeldt E, Darenberg J, Örtqvist Å, Henriques-Normark B (2017) Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations. Clin Infect Dis 65(11):1780–1790
Mostowy RJ, Croucher NJ, De Maio N, Chewapreecha C, Salter SJ, Turner P, Fraser C (2017) Pneumococcal capsule synthesis locus cps as evolutionary hotspot with potential to generate novel serotypes by recombination. Mol Biol Evol 34(10):2537–2554
Trzciński K, Thompson CM, Lipsitch M (2004) Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol 186(11):3447–3452
Shainheit MG, Valentino MD, Gilmore MS, Camilli A (2015) Mutations in pneumococcal cpsE generated via in vitro serial passaging reveal a potential mechanism of reduced encapsulation utilized by a conjunctival isolate. J Bacteriol 197(10):1781–1791
Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ (2008) Streptococcus pneumoniae serotype 19A in children. South Korea Emerg Infect Dis 14:275
Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J (2009) Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 64:507–510
Pillai DR, Shahinas D, Buzina A, Pollock RA, Lau R, Khairnar K, Low DE (2009) Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 10:642
Hsieh YC, Chang KY, Huang YC, Lin HC, Ho YH, Huang LM, Hsueh PR (2008) Clonal spread of highly β-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrob Agents Chemother 52:2266–2269
Ruiz García Y, Nieto Guevara J, Izurieta P, Vojtek I, Ortega-Barría E, Guzman-Holst A (2021) Circulating clonal complexes and sequence types of Streptococcus pneumoniae serotype 19a worldwide: the importance of multidrug resistance a systematic literature review. Exp Rev Vaccines 20:45–57
Balaji V, Jayaraman R, Verghese VP, Baliga PR, Kurien T (2015) Pneumococcal serotypes associated with invasive disease in under five children in India & implications for vaccine policy. Indian J Med Res 142(3):286
Thomas K, Kesavan LM, Veeraraghavan B, Jasmine S, Jude J, Shubankar M, Network ISGI (2013) Invasive pneumococcal disease associated with high case fatality in India. J Clin Epidemiol 66(1):36–43
Molander V, Elisson C, Balaji V, Backhaus E, John J, Vargheese R, Andersson R (2013) Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes. BMC Infect Dis 13(1):532
Varghese R, Neeravi A, Subramanian N, Pavithra B, Kavipriya A, Kumar JL, Veeraraghavan B (2019) Clonal similarities and sequence-type diversity of invasive and carriage Streptococcus pneumoniae in India among children under 5 Years. Indian J Med Microbiol 37(3):358
Gopi T, Ranjith J, Anandan S, Balaji V (2016) Epidemiological characterisation of Streptococcus pneumoniae from India using multilocus sequence typing. Indian J Med Microbiol 34(1):17
Shariff M, Choudhary J, Zahoor S, Deb M (2013) Characterization of Streptococcus pneumoniae isolates from India with special reference to their sequence types. J Infect Dev Countries 7(02):101–109
Shariff M, Thukral SS, Beall B (2007) New multilocus sequence types of Streptococcus pneumoniae isolates from patients with respiratory infections in India. Indian J Med Res 126(2):161
Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Rudan I (2018) Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health 6(7):e744–e757
Farooqui H, Jit M, Heymann DL, Zodpey S (2015) Burden of severe pneumonia, pneumococcal pneumonia and pneumonia deaths in Indian states: modelling based estimates. PLoS ONE 10(6):e0129191
World Health Organization (2011) Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. WHO manual. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. WHO manual. (Ed. 2).
Enright MC, Spratt BG (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144(11):3049–3060
Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RE, Walker H, Beall BW (2017) Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences. BMC Genomics 18(1):1–10
Grant JR, Stothard P (2008) The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res 36:W181–W184
Chesnel L, Carapito R, Croizé J, Dideberg O, Vernet T, Zapun A (2005) Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of β-lactam resistance. Antimicrob Agents Chemother 49(7):2895–2902
Fani F, Brotherton MC, Leprohon P, Ouellette M (2013) Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae. J Antimicrob Chemother 68(8):1718–1727
Gámez G, Castro A, Gómez-Mejia A, Gallego M, Bedoya A, Camargo M, Hammerschmidt S (2018) The variome of pneumococcal virulence factors and regulators. BMC Genomics 19(1):10
Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Samuel G (2006) Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2(3):e31
Elberse K, Witteveen S, Van Der Heide H, Van De Pol I, Schot C, Van Der Ende A, Schouls L (2011) Sequence diversity within the capsular genes of Streptococcus pneumoniae serogroup 6 and 19. PLoS ONE 6(9):e25018
Ip M, Ang I, Liyanapathirana V, Ma H, Lai R (2015) Genetic analyses of penicillin binding protein determinants in multidrug-resistant Streptococcus pneumoniae serogroup 19 CC320/271 clone with high-level resistance to third generation cephalosporins. Antimicrob Agents Chemother 59(7):4040–4045
Brugger SD, Troxler LJ, Rüfenacht S, Frey PM, Morand B, Geyer R, Hilty M (2016) Polysaccharide capsule composition of pneumococcal serotype 19A subtypes is unaltered among subtypes and independent of the nutritional environment. Infect Immun 84(11):3152–3160
Briles DE, Hollingshead S, Brooks-Walter A, Nabors GS, Ferguson L, Schilling M, Swift A (2000) The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 18(16):1707–1711
Ahmed MS, Derbyshire S, Flanagan B, Loh C, McCormick M, Barocchi M, Zhang Q (2014) Immune responses to pneumococcal pilus RrgA and RrgB antigens and their relationship with pneumococcal carriage in humans. J Infect 68(6):562–571
Argondizzo APC, Rocha-de-Souza CM, de Almeida Santiago M, Galler R, Reis JN, Medeiros MA (2017) Pneumococcal predictive proteins selected by microbial genomic approach are serotype cross-reactive and bind to host extracellular matrix proteins. Appl Biochem Biotechnol 182(4):1518–1539
Muñoz-Almagro C, Selva L, Sanchez CJ, Esteva C, De Sevilla MF, Pallares R, Orihuela CJ (2010) PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type. Clin Vaccine Immunol 17(11):1672–1678
Shivshankar P, Sanchez C, Rose LF, Orihuela CJ (2009) The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells. Mol Microbiol 73(4):663–679
Žemličková H, Mališová L, Španělová P, Jakubů V, Kozáková J, Musílek M, Medvecký M (2018) Molecular characterization of serogroup 19 Streptococcus pneumoniae in the Czech Republic in the post-vaccine era. J Med Microbiol 67(7):1003
Chen H, Ma Y, Yang J, O’Brien CJ, Lee SL, Mazurkiewicz JE, Zhang JR (2008) Genetic requirement for pneumococcal ear infection. PLoS ONE 3(8):e2950
McAllister LJ, Ogunniyi AD, Stroeher UH, Paton JC (2012) Contribution of a genomic accessory region encoding a putative cellobiose phosphotransferase system to virulence of Streptococcus pneumoniae. PLoS ONE 7(2):e32385
Pettigrew MM, Fennie KP (2005) Genomic subtraction followed by dot blot screening of Streptococcus pneumoniae clinical and carriage isolates identifies genetic differences associated with strains that cause otitis media. Infect Immun 73(5):2805–2811
Chen YY, Wang JT, Lin TL, Gong YN, Li TH, Huang YY, Hsieh YC (2019) Prophage excision in Streptococcus pneumoniae serotype 19A ST320 promote colonization: insight into its evolution from the ancestral clone Taiwan 19F–14 (ST236). Front Microbiol 10:205
Jensen A, Valdórsson O, Frimodt-Møller N, Hollingshead S, Kilian M (2015) Commensal streptococci serve as a reservoir for β-lactam resistance genes in Streptococcus pneumoniae. Antimicrob Agents Chemother 59(6):3529–3540
Hakenbeck R, Grebe T, Zähner D, Stock JB (1999) β-Lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins. Mol Microbiol 33(4):673–678
Hakenbeck R, Brückner R, Denapaite D, Maurer P (2012) Molecular mechanisms of β-lactam resistance in Streptococcus pneumoniae. Future Microbiol 7(3):395–410
Song JH, Dagan R, Klugman KP, Fritzell B (2012) The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 30(17):2728–2737
Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L, van der Linden M, Yang F (2014) Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol 6(7):1589–1602
Verghese VP, Veeraraghavan B, Jayaraman R, Varghese R, Neeravi A, Jayaraman Y, Mehendale SM (2017) Increasing incidence of penicillin-and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: time for revision of treatment guidelines? Indian J Med Microbiol 35(2):228
Varghese R, Neeravi A, Subramanian N, Baskar P, Anandhan K, Veeraraghavan B (2020) Analysis of amino acid sequences of penicillin-binding proteins 1a, 2b, and 2x in invasive Streptococcus pneumoniae nonsusceptible to penicillin isolated from children in India. Microb Drug Resistance 27:311–319
Acknowledgements
The authors thank Department of clinical Microbiology, Christian Medical College (CMC), Vellore for providing all necessary facilities and Ms. Catherine Trueman (Clinical Pharmacist) for helping in language editing.
Genome sequence accession numbers
The accession numbers of the WGS of the seven study isolates are NIFF00000000, NIFG00000000, VBQV0000000, VUOM0000000, VUOO00000000, VUON00000000 and VUOP00000000.
Funding
The study has been partly supported by the Christian Medical College institutional review board (IRB Min.No: 8200).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
The study has been approved by Christian Medical College institutional review board (IRB Min.No:8200).
Informed consent
Since this study is performed on archived isolates and do not involve any patients informed consent is not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Varghese, R., Neeravi, A., Jacob, J.J. et al. Comparative genomics of invasive Streptococcus pneumoniae CC320/271 serotype 19F/19A before the introduction of pneumococcal vaccine in India. Mol Biol Rep 48, 3265–3276 (2021). https://doi.org/10.1007/s11033-021-06353-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06353-6